Adipose derived stem cells (Cytori Therapeutics)
N/A
Report date: 2024/03/07 13:13:11
Base Information
Drug NameAdipose derived stem cells (Cytori Therapeutics)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAssistance Publique - Hopitaux De MarseilleNagoya UniversityCytori Therapeutics
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesAssistance Publique - Hopitaux De MarseilleNagoya University
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A